Christian Bernard Matthijs Poulie

Title: Christian Bernard Matthijs Poulie: Innovator in Pharmaceutical Science

Introduction

Christian Bernard Matthijs Poulie is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceutical science, particularly in the development of FSH receptor antagonists. With a total of two patents to his name, Poulie's work has the potential to impact various medical treatments.

Latest Patents

Poulie's latest patents focus on FSH receptor antagonists, which are compounds that can be used for the treatment and prevention of endometriosis. These inventions also target pre-menopausal and peri-menopausal hormone-dependent breast cancer, contraception, and the treatment of uterine fibroids and other menstrual-related disorders. The compounds are described by a general formula and can be formulated into pharmaceutical compositions for effective use.

Career Highlights

Christian Bernard Matthijs Poulie is currently associated with Merck Sharp & Dohme B.V., a leading company in the pharmaceutical industry. His work at Merck has allowed him to explore innovative solutions to pressing health issues, particularly those affecting women's health.

Collaborations

Poulie has collaborated with notable colleagues such as Wesley Peter Blackaby and Martin De Kort. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Christian Bernard Matthijs Poulie's contributions to pharmaceutical science, particularly through his patents on FSH receptor antagonists, highlight his role as an innovator in the field. His work has the potential to improve treatment options for various health conditions, making a significant impact on women's health.